Farmaceutica R (RO:RMAH) — Stock Price
Farmaceutica R (RO:RMAH) is currently trading at RON0.88 RON, up 0.23% today. Over the past 52 weeks, shares have ranged between RON0.69 and RON0.94. This page tracks Farmaceutica R's live share price on the RO exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. To understand the scale of the balance sheet behind this price, see RMAH total asset value.
Farmaceutica R (RMAH) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Farmaceutica R's daily closing share price and trading volume on the RO exchange over the past year, giving a clear view of recent price momentum and liquidity.
Farmaceutica R Income Statement — Revenue, Profit & Earnings by Year
Farmaceutica R's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | RON759.76 Million | RON743.79 Million | RON593.36 Million | RON535.85 Million | RON477.10 Million |
| Cost of Revenue | RON699.23 Million | RON685.78 Million | RON547.53 Million | RON491.42 Million | RON439.09 Million |
| Gross Profit | RON60.53 Million | RON58.01 Million | RON45.83 Million | RON44.43 Million | RON38.01 Million |
| Research & Development | — | — | — | — | — |
| SG&A | — | — | RON1.94 Million | RON2.22 Million | RON1.74 Million |
| Total Operating Expenses | RON744.53 Million | RON730.49 Million | RON585.83 Million | RON528.71 Million | RON468.31 Million |
| Operating Income | RON15.23 Million | RON13.31 Million | RON7.53 Million | RON7.14 Million | RON8.79 Million |
| EBITDA | — | — | — | — | — |
| EBIT | — | — | — | — | — |
| Interest Expense | RON48.12K | RON104.30K | RON121.56K | RON162.30K | RON109.56K |
| Income Before Tax | RON16.35 Million | RON14.09 Million | RON8.91 Million | RON7.06 Million | RON8.63 Million |
| Income Tax Expense | — | — | — | — | — |
| Net Income | RON8.72 Million | RON6.96 Million | RON7.20 Million | RON5.81 Million | RON7.23 Million |
Farmaceutica R Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Farmaceutica R's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | RON384.68 Million | RON376.03 Million | RON315.76 Million | RON286.20 Million | RON251.07 Million |
| Total Current Assets | RON332.68 Million | RON327.80 Million | RON268.99 Million | RON241.72 Million | RON208.42 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | RON203.88 Million | RON216.95 Million | RON184.26 Million | RON173.70 Million | RON137.63 Million |
| Inventory | RON63.51 Million | RON57.21 Million | RON44.33 Million | RON46.26 Million | RON40.60 Million |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | — | — | — | — | — |
| Total Liabilities | RON303.69 Million | RON301.09 Million | RON244.90 Million | RON217.77 Million | RON182.85 Million |
| Total Current Liabilities | RON298.25 Million | RON295.90 Million | RON239.45 Million | RON214.60 Million | RON180.30 Million |
| Long-term Debt | — | — | — | — | — |
| Net Debt | — | — | — | — | — |
| Total Stockholder Equity | RON80.99 Million | RON74.94 Million | RON70.86 Million | RON68.43 Million | RON68.22 Million |
| Retained Earnings | RON26.74 Million | RON23.89 Million | RON21.54 Million | RON17.97 Million | RON13.66 Million |
Farmaceutica R Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Farmaceutica R generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year |
|---|
| Operating Cash Flow |
| Capital Expenditures |
| Free Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
| Dividends Paid |
| Stock-Based Compensation |
| Depreciation |
| Change in Cash |
Farmaceutica R Earnings History — EPS Actual vs. Analyst Estimates
Track Farmaceutica R's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 14, 2025 | — | — | — |
| Feb 26, 2025 | — | — | — |
| Feb 23, 2023 | 0.06 | 0.00 | — |
| Nov 10, 2022 | 0.01 | 0.00 | — |
| Aug 12, 2022 | 0.02 | 0.00 | — |
| May 12, 2022 | 0.02 | 0.00 | — |
| Feb 16, 2022 | 0.07 | 0.00 | — |
| Nov 11, 2021 | 0.02 | 0.00 | — |